Riyadh: The Seha Virtual Hospital, through its Digital Clinical Research Center, has successfully conducted a pioneering clinical study to verify the accuracy of the AI-powered digital platform (iSelfie.ai) in the early detection of heart disease and related chronic conditions. The study included over a thousand participants and received necessary approval from the Saudi Food and Drug Authority (SFDA) and the Research and Studies General Department.

According to Saudi Press Agency, the clinical trial was conducted in collaboration with a select group of leading national medical institutions, reflecting the importance of such partnerships in advancing medical research in the Kingdom.

The study’s primary goal was to verify the accuracy of the Canadian-developed iSelfie.ai platform, which uses artificial intelligence to analyze facial selfies taken with a standard smartphone camera. Within seconds, it can measure vital signs such as blood pressure, heart rate, oxygen saturation, and respiratory rate.

The study’s results demonstrated that the platform’s accuracy is comparable to traditional medical devices, positioning it as an innovative, rapid, and cost-effective solution for early diagnosis. This technology had previously achieved promising results in terms of accuracy and reliability during clinical trials conducted in the United States, Canada, and Brazil.

The Digital Clinical Research Center, launched during the Global Health Exhibition 2024, continues to conduct five pioneering digital studies encompassing artificial intelligence, wearable devices, and telemedicine. This entire initiative aligns with a strategic direction to accelerate treatment development, enhance research innovation, and empower healthcare professionals with advanced tools, ultimately contributing to improved quality of life and patient safety, consistent with the goals of the health transformation and Vision 2030.